CN Patent

CN113980014B — 氢化吡啶并嘧啶类衍生物、其制备方法及其在医药上的应用

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2023-05-12 · 3y expired

What this patent protects

本公开涉及氢化吡啶并嘧啶类衍生物、其制备方法及其在医药上的应用。具体而言，本公开涉及具体的氢化吡啶并嘧啶类衍生物、其制备方法及含有该衍生物的药物组合物以及其作为治疗剂，特别是作为KRAS抑制剂的用途。

USPTO Abstract

本公开涉及氢化吡啶并嘧啶类衍生物、其制备方法及其在医药上的应用。具体而言，本公开涉及具体的氢化吡啶并嘧啶类衍生物、其制备方法及含有该衍生物的药物组合物以及其作为治疗剂，特别是作为KRAS抑制剂的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN113980014B
Jurisdiction
CN
Classification
—
Expires
2023-05-12
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hengrui Medicine Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.